alprazolam has been researched along with Depression in 45 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The adjunct of alprazolam to a psychologic support program delays the occurrence of anticipatory nausea and controls sleeping problems secondary to adjunct CT." | 9.07 | Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. ( Beauduin, M; De Brier, F; Delvaux, N; Derde, MP; Farvacques, C; Kaufman, L; Piccart, M; Razavi, D; Van Heer, C, 1993) |
| "We observed no significant differences in the severity of premenstrual symptom ratings during alprazolam administration compared with placebo on any scale except the Beck Depression Inventory Scale." | 9.07 | Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. ( Grover, GN; Rubinow, DR; Schmidt, PJ, 1993) |
| "The effectiveness of alprazolam in treating symptoms of anxiety and depression in 60 patients undergoing coronary bypass surgery was assessed in a double-blind, placebo-controlled study." | 9.06 | Alprazolam treatment of postcoronary bypass anxiety and depression. ( Fleece, L; Folks, DG; Freeman, AM; Hall, KR; Karp, RB; Kirklin, JK; McGiffin, DC; Pacifico, AD; Sokol, RS; Zorn, GL, 1986) |
| "One hundred patients with mixed symptoms of anxiety and depression were enrolled into a prospective, multi-centre, randomized, double-blind study comparing the response to, and the side-effects of, alprazolam and dothiepin hydrochloride over 4 weeks of treatment." | 9.06 | A double-blind comparative study of alprazolam and dothiepin hydrochloride in the treatment of anxiety associated with depression. ( Baker, AC; Cropper, M; Garner, A; McEwan, GD; Munt, DF; Rushbrook, LA; Stevens, V, 1987) |
| "The 'off-label' effect of alprazolam on depression has not been systematically evaluated." | 8.88 | Alprazolam for depression. ( Allick, G; Bax, A; Riphagen, II; van Marwijk, H; Wegman, F, 2012) |
| "A meta-analysis of well-controlled studies of alprazolam in depression was performed to assess the possible association of alprazolam and suicidal ideation." | 8.79 | Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. ( Hearron, AE; Jonas, JM, 1996) |
| "This study investigated an anxiety-prone cognitive style (measured by the Anxious Thoughts and Tendencies Questionnaire, AT&T) as a predictor of the acute response to increasing alprazolam plasma levels in panic disorder." | 7.74 | Cognitive style, alprazolam plasma levels, and treatment response in panic disorder. ( Antal, EJ; Barnhill, J; Javaid, JI; Matuzas, W; Qualls, C; Starcevic, V; Uhlenhuth, EH, 2008) |
| "Of 147 cancer patients who met entry levels of distress and completed the study, uncontrolled for site or disease stage, 70 were randomized to drug, 77 to relaxation." | 6.67 | A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. ( Berenson, S; Breitbart, W; Carpenter, PJ; Derogatis, L; Feldstein, M; Holland, JC; Morrow, GR; Schmale, A; Stefanek, M, 1991) |
| "The clinical efficacy of alprazolam has been evaluated in both anxiety states and depressive disorders." | 6.15 | Brief review of published alprazolam clinical studies. ( Straw, RN, 1985) |
| "Reserpine was added for both antipsychotic coverage and reported beneficial effects in the treatment of TD." | 5.27 | Alprazolam reversal of reserpine-induced depression in patients with compensated tardive dyskinesia. ( Holt, RJ, 1984) |
| " Comparison of anti-anxiety and antidepressant effects of alprazolam and diazepam in patients treated with systemic chemotherapy." | 5.11 | [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases]. ( Bucior, J; Foltyn, W; Jastrzebska-Okoń, K; Kempiński, M; Knopik, J; Tomczyk, A; Ziółko, E, 2004) |
| " By the response of the patients to alprazolam (anxiolytic) and fluoketin (antidepressant) given by a special scheme, 3 types of comorbidity of obsessional-phobic and affective disturbances were recognized: 1) prevalent depression, 2) combination of dysthymia with marked obsessional-phobic disorders, 3) overcoming of obsessional-phobic and affective disorders." | 5.07 | [The psychopharmacotherapy of anxious-depressive states (the interrelationship of the structure of the comorbidity to the choice of drug therapy)]. ( Andriushchenko, AV; Koliutskaia, EV; Morkovkina, IV; Smulevich, AB; Tkhostov, ASh, 1994) |
| "The adjunct of alprazolam to a psychologic support program delays the occurrence of anticipatory nausea and controls sleeping problems secondary to adjunct CT." | 5.07 | Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. ( Beauduin, M; De Brier, F; Delvaux, N; Derde, MP; Farvacques, C; Kaufman, L; Piccart, M; Razavi, D; Van Heer, C, 1993) |
| "We observed no significant differences in the severity of premenstrual symptom ratings during alprazolam administration compared with placebo on any scale except the Beck Depression Inventory Scale." | 5.07 | Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. ( Grover, GN; Rubinow, DR; Schmidt, PJ, 1993) |
| "A double-blind study was carried out in 30 female patients with generalized anxiety disorders associated with depressive symptoms to compare the effectiveness and tolerability of etizolam and alprazolam." | 5.06 | Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms. ( Caddeo, S; Ecari, U; Pariante, F, 1989) |
| "The effectiveness of alprazolam in treating symptoms of anxiety and depression in 60 patients undergoing coronary bypass surgery was assessed in a double-blind, placebo-controlled study." | 5.06 | Alprazolam treatment of postcoronary bypass anxiety and depression. ( Fleece, L; Folks, DG; Freeman, AM; Hall, KR; Karp, RB; Kirklin, JK; McGiffin, DC; Pacifico, AD; Sokol, RS; Zorn, GL, 1986) |
| "Alprazolam is a benzodiazepine derivative that is currently used in the treatment of generalized anxiety, panic attacks with or without agoraphobia, and depression." | 4.82 | Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature. ( Verster, JC; Volkerts, ER, 2004) |
| "Doctors should closely monitor the severity of alprazolam dependence among long-term users, especially patients' levels of depression, beliefs in the necessity of alprazolam treatment, and their concerns over the adverse consequences of continued treatment with alprazolam." | 3.81 | Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan. ( Chen, ST; Chen, TT; Hwang, TJ; Ko, CH; Lin, JJ; Su, PW; Yen, CF; Yen, CN, 2015) |
| "This study investigated an anxiety-prone cognitive style (measured by the Anxious Thoughts and Tendencies Questionnaire, AT&T) as a predictor of the acute response to increasing alprazolam plasma levels in panic disorder." | 3.74 | Cognitive style, alprazolam plasma levels, and treatment response in panic disorder. ( Antal, EJ; Barnhill, J; Javaid, JI; Matuzas, W; Qualls, C; Starcevic, V; Uhlenhuth, EH, 2008) |
| "A 30-year-old woman, with history of depression, was found dead after the ingestion of an unknown quantity of Xanax (alprazolam), Tramal (tramadol) and alcohol." | 3.70 | Fatal overdose of tramadol and alprazolam. ( Augsburger, M; Giroud, C; Mangin, P; Michaud, K; Romain, N, 1999) |
| "Of 147 cancer patients who met entry levels of distress and completed the study, uncontrolled for site or disease stage, 70 were randomized to drug, 77 to relaxation." | 2.67 | A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. ( Berenson, S; Breitbart, W; Carpenter, PJ; Derogatis, L; Feldstein, M; Holland, JC; Morrow, GR; Schmale, A; Stefanek, M, 1991) |
| "The alprazolam effects were apparent by week 1; the imipramine effects by week 4." | 2.67 | Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. ( Agras, WS; Clark, D; Ehlers, A; Hayward, C; King, R; Maddock, R; Margraf, J; Roth, WT; Taylor, CB, 1990) |
| "Reserpine was added for both antipsychotic coverage and reported beneficial effects in the treatment of TD." | 1.27 | Alprazolam reversal of reserpine-induced depression in patients with compensated tardive dyskinesia. ( Holt, RJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (28.89) | 18.7374 |
| 1990's | 18 (40.00) | 18.2507 |
| 2000's | 7 (15.56) | 29.6817 |
| 2010's | 7 (15.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarrete, F | 1 |
| García-Gutiérrez, MS | 1 |
| Laborda, J | 1 |
| Manzanares, J | 1 |
| Juřica, J | 1 |
| Žourková, A | 1 |
| El Zahaf, NA | 1 |
| Salem Elhwuegi, A | 1 |
| Chen, TT | 1 |
| Ko, CH | 1 |
| Chen, ST | 1 |
| Yen, CN | 1 |
| Su, PW | 1 |
| Hwang, TJ | 1 |
| Lin, JJ | 1 |
| Yen, CF | 1 |
| Francino, MC | 1 |
| Bretaudeau Deguigne, M | 1 |
| Badin, J | 1 |
| Turcant, A | 1 |
| Perrotin, D | 1 |
| Novío, S | 1 |
| Núñez, MJ | 1 |
| Ponte, CM | 1 |
| Freire-Garabal, M | 1 |
| van Marwijk, H | 1 |
| Allick, G | 1 |
| Wegman, F | 1 |
| Bax, A | 1 |
| Riphagen, II | 1 |
| Boerner, RJ | 1 |
| Verster, JC | 1 |
| Volkerts, ER | 1 |
| Ziółko, E | 1 |
| Knopik, J | 1 |
| Bucior, J | 1 |
| Foltyn, W | 1 |
| Jastrzebska-Okoń, K | 1 |
| Tomczyk, A | 1 |
| Kempiński, M | 1 |
| Uhlenhuth, EH | 1 |
| Starcevic, V | 1 |
| Qualls, C | 1 |
| Antal, EJ | 1 |
| Matuzas, W | 1 |
| Javaid, JI | 1 |
| Barnhill, J | 1 |
| Koval'chuk, VV | 1 |
| Barthelmé, B | 1 |
| Poirot, Y | 1 |
| Sethy, VH | 1 |
| Hodges, DH | 1 |
| Draper, RJ | 1 |
| Daly, I | 1 |
| Jaffe, K | 1 |
| Barnshaw, HD | 1 |
| Weingourt, R | 1 |
| Kennedy, M | 1 |
| Holt, RJ | 1 |
| Ayd, FJ | 1 |
| Friedman, MJ | 1 |
| Stolk, JM | 1 |
| Harris, PQ | 1 |
| Cooper, TB | 1 |
| Laakman, G | 1 |
| Faltermaier-Temizel, M | 1 |
| Bossert-Zaudig, S | 1 |
| Baghai, T | 1 |
| Lorkowski, G | 1 |
| Cannizzaro, C | 2 |
| Cannizzaro, E | 1 |
| Gagliano, M | 2 |
| Mineo, A | 1 |
| Sabatino, M | 1 |
| Cannizzaro, G | 2 |
| Vendittelli, F | 1 |
| Alain, J | 1 |
| Nouaille, Y | 1 |
| Brosset, A | 1 |
| Tabaste, JL | 1 |
| Smulevich, AB | 1 |
| Andriushchenko, AV | 1 |
| Morkovkina, IV | 1 |
| Tkhostov, ASh | 1 |
| Koliutskaia, EV | 1 |
| Razavi, D | 1 |
| Delvaux, N | 1 |
| Farvacques, C | 1 |
| De Brier, F | 1 |
| Van Heer, C | 1 |
| Kaufman, L | 1 |
| Derde, MP | 1 |
| Beauduin, M | 1 |
| Piccart, M | 1 |
| Schmidt, PJ | 1 |
| Grover, GN | 1 |
| Rubinow, DR | 1 |
| Ketter, TA | 1 |
| Callahan, AM | 1 |
| Post, R | 1 |
| Jonas, JM | 1 |
| Hearron, AE | 1 |
| Pazzagli, L | 1 |
| Banfi, R | 1 |
| Borselli, G | 1 |
| Semmola, MV | 1 |
| Parker, RA | 1 |
| Hartman, EE | 1 |
| Michaud, K | 1 |
| Augsburger, M | 1 |
| Romain, N | 1 |
| Giroud, C | 1 |
| Mangin, P | 1 |
| Raghavendra, V | 1 |
| Kaur, G | 1 |
| Kulkarni, SK | 1 |
| Flugy, A | 1 |
| Novara, V | 1 |
| Rimón, R | 1 |
| Kultalahti, ER | 1 |
| Kalli, A | 1 |
| Koskinen, T | 1 |
| Lepola, U | 1 |
| Naarala, M | 1 |
| Tick, E | 1 |
| Russell, IJ | 1 |
| Fletcher, EM | 1 |
| Michalek, JE | 1 |
| McBroom, PC | 1 |
| Hester, GG | 1 |
| Holland, JC | 1 |
| Morrow, GR | 1 |
| Schmale, A | 1 |
| Derogatis, L | 1 |
| Stefanek, M | 1 |
| Berenson, S | 1 |
| Carpenter, PJ | 1 |
| Breitbart, W | 1 |
| Feldstein, M | 1 |
| Penati, G | 1 |
| Panza, G | 1 |
| Mantero, M | 1 |
| Mauri, MC | 1 |
| Taylor, CB | 1 |
| Hayward, C | 1 |
| King, R | 1 |
| Ehlers, A | 1 |
| Margraf, J | 1 |
| Maddock, R | 1 |
| Clark, D | 1 |
| Roth, WT | 1 |
| Agras, WS | 1 |
| Lopez, AL | 1 |
| Kathol, RG | 1 |
| Noyes, R | 1 |
| Pariante, F | 1 |
| Caddeo, S | 1 |
| Ecari, U | 1 |
| Straw, RN | 1 |
| Freeman, AM | 1 |
| Fleece, L | 1 |
| Folks, DG | 1 |
| Sokol, RS | 1 |
| Hall, KR | 1 |
| Pacifico, AD | 1 |
| McGiffin, DC | 1 |
| Kirklin, JK | 1 |
| Zorn, GL | 1 |
| Karp, RB | 1 |
| Cropper, M | 1 |
| Garner, A | 1 |
| McEwan, GD | 1 |
| Munt, DF | 1 |
| Rushbrook, LA | 1 |
| Stevens, V | 1 |
| Baker, AC | 1 |
| Biraghi, M | 1 |
| Fano, M | 1 |
| Bernareggi, V | 1 |
| Väisänen, E | 1 |
| Jalkanen, E | 1 |
| Corkery, JC | 1 |
5 reviews available for alprazolam and Depression
| Article | Year |
|---|---|
Alprazolam for depression.
Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Depression; Humans; Middle Aged; Randomized Controll | 2012 |
[Panic attacks and panic disorder. Checklist for the diagnosis].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2003 |
Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Automobile Driving; Behavior; Clinical | 2004 |
Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression.
Topics: Alprazolam; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Hypnotics and Sedativ | 1996 |
Brief review of published alprazolam clinical studies.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Depression; Hum | 1985 |
19 trials available for alprazolam and Depression
| Article | Year |
|---|---|
Dynamics and persistence of CYP2D6 inhibition by paroxetine.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhib | 2013 |
[Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antineoplastic Combined Chemotherapy Protocols; Anxiet | 2004 |
[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Neoplas | 2007 |
Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiaze | 1983 |
Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Antidepressive Agents; Depression; Female; Humans; Lorazepam | 1995 |
[The psychopharmacotherapy of anxious-depressive states (the interrelationship of the structure of the comorbidity to the choice of drug therapy)].
Topics: Adult; Alprazolam; Anxiety; Comorbidity; Depression; Double-Blind Method; Female; Fluoxetine; Humans | 1994 |
Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.
Topics: Adjustment Disorders; Adult; Aged; Alprazolam; Anxiety; Breast Neoplasms; Chemotherapy, Adjuvant; De | 1993 |
Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
Topics: Adult; Alprazolam; Anxiety; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug | 1993 |
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam | 1991 |
Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Alprazolam; Depression; Double-Blind Method; Fibromyalgia; Humans; Ibuprofe | 1991 |
A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms.
Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Behavior Therapy; Depression; Female; Humans; Male; Midd | 1991 |
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi | 1990 |
Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Benzodiazepines; Depression; Diazepam; Fear; Female; Humans; Hydroco | 1990 |
Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Consumer Behavior; Depression; Diazepam; Double-Blind Method; | 1989 |
Brief review of published alprazolam clinical studies.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Depression; Hum | 1985 |
Alprazolam treatment of postcoronary bypass anxiety and depression.
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Benzodiazepines; Clini | 1986 |
A double-blind comparative study of alprazolam and dothiepin hydrochloride in the treatment of anxiety associated with depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety; Clinical Trials as Topic; Depression; Dibenzothiepins; | 1987 |
[Multicenter clinical experimentation with alprazolam].
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depression; Female; Humans; Male; Panic | 1986 |
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle | 1987 |
22 other studies available for alprazolam and Depression
| Article | Year |
|---|---|
Deletion of Dlk2 increases the vulnerability to anxiety-like behaviors and impairs the anxiolytic action of alprazolam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Depression; Disease Models, Ani | 2017 |
The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.
Topics: Alprazolam; Animals; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; | 2014 |
Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan.
Topics: Adult; Alprazolam; Ambulatory Care Facilities; Anti-Anxiety Agents; Anxiety Disorders; Comorbidity; | 2015 |
Hypoglycaemia: a little known effect of Venlafaxine overdose.
Topics: Adult; Alprazolam; Analgesics; Anti-Anxiety Agents; Cyclohexanols; Depression; Drug Overdose; Drug T | 2012 |
Urinary biopyrrins: potential biomarker for monitoring of the response to treatment with anxiolytics.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Bilirubin; Biomarkers; Corticosterone; Depression; Enzyme- | 2012 |
Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Cognition; Depression; Diagnostic and S | 2008 |
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardio | 2008 |
Alprazolam in a biochemical model of depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Depression; Diazepam; Disease Models, Ani | 1982 |
Comparison of alprazolam with imipramine and placebos.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depression; Humans; Imipramine | 1984 |
Alprazolam reversal of reserpine-induced depression in patients with compensated tardive dyskinesia.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depression; Dyskinesia, Drug-Induced; Human | 1984 |
Is it anxiety or depression?
Topics: Aged; Alprazolam; Antidepressive Agents; Anxiety; Benzodiazepines; Circadian Rhythm; Depression; Dia | 1984 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde | 1984 |
Effects of desipramine and alprazolam on forced swimming behaviour of adult rats exposed to prenatal diazepam.
Topics: Alprazolam; Animals; Behavior, Animal; Depression; Desipramine; Diazepam; Electroencephalography; El | 1995 |
A case of lipomeningocele reported with fluoxetine (and alprazolam, vitamins B1 and B6, heptaminol) prescribed during pregnancy.
Topics: Adult; Alprazolam; Depression; Drug Therapy, Combination; Female; Fluoxetine; Heptaminol; Humans; In | 1995 |
Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
Topics: Alprazolam; Antidepressive Agents, Second-Generation; Anxiety; Cytochrome P-450 Enzyme Inhibitors; D | 1996 |
Photosensitivity reaction to fluoxetine and alprazolam.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Depression; Ethiopia; Fluoxetine; Human | 1998 |
An 87-year-old woman taking a benzodiazepine, 1 year later.
Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; | 1999 |
Fatal overdose of tramadol and alprazolam.
Topics: Adult; Alcoholic Intoxication; Alprazolam; Analgesics, Opioid; Anti-Anxiety Agents; Autopsy; Cause o | 1999 |
Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation.
Topics: Alprazolam; Analysis of Variance; Animals; Anti-Anxiety Agents; Antioxidants; Benzodiazepinones; Bic | 2000 |
Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Depression; Desipramine; | 1992 |
Paranoid ideation in geriatric depressed patients treated with alprazolam.
Topics: Aged; Aging; Alprazolam; Depression; Female; Humans; Male; Middle Aged; Paranoid Disorders | 1991 |
Recognition and treatment of depression.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depression; F | 1987 |